BeStock  
Markets › Compare › LTGO vs MRVI

LTGO vs MRVI

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
LTGO · Latigo Biotherapeutics$15.52 ▼ 4.55%
MRVI · Maravai LifeSciences$7.43 ▼ 5.35%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

8198115131148Aug 7, '26Sep 8, '26Oct 7, '26
  • LTGO -15.0%
  • MRVI +19.3%

Head to head

MetricLTGOMRVI
Price$15.52$7.43
Change today▼ 4.55%▼ 5.35%
Market cap$1.03B$1.11B
Return, 3 months–+24.5%
Return, year to date–+128.6%
Return, 1 year–+123.1%
P/E (TTM)-9.3-14.0
P/B-3.75.4
P/E percentile vs own 5y91st1st
Dividend yield––
Revenue growth (YoY, latest qtr)–+8.5%
Net profit growth (YoY)+0.1%+69.0%
Gross margin–34.9%
Operating margin–-33.7%
Net margin–-37.1%
Return on equity–-32.9%
Analyst target vs. price+271.6%+5.4%
Analyst buy share100%80%
RSI (14)3350
30-day volatility73.3%62.7%
Max drawdown, 1 year-37.9%-29.6%
Trend readStrong downtrendStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • MRVI is the largest of the group by market value.
  • MRVI carries the lowest trailing P/E.
  • MRVI has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top